BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36821091)

  • 1. High-Throughput Screening of ToxCast PFAS Chemical Library for Potential Inhibitors of the Human Sodium Iodide Symporter.
    Stoker TE; Wang J; Murr AS; Bailey JR; Buckalew AR
    Chem Res Toxicol; 2023 Mar; 36(3):380-389. PubMed ID: 36821091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of potential sodium-iodide symporter (NIS) inhibitors using a secondary Fischer rat thyroid follicular cell (FRTL-5) radioactive iodide uptake (RAIU) assay.
    Buckalew AR; Wang J; Murr AS; Deisenroth C; Stewart WM; Stoker TE; Laws SC
    Arch Toxicol; 2020 Mar; 94(3):873-885. PubMed ID: 32065294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded high-throughput screening and chemotype-enrichment analysis of the phase II: e1k ToxCast library for human sodium-iodide symporter (NIS) inhibition.
    Wang J; Richard AM; Murr AS; Buckalew AR; Lougee RR; Shobair M; Hallinger DR; Laws SC; Stoker TE
    Arch Toxicol; 2021 May; 95(5):1723-1737. PubMed ID: 33656581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screening and chemotype-enrichment analysis of ToxCast phase II chemicals evaluated for human sodium-iodide symporter (NIS) inhibition.
    Wang J; Hallinger DR; Murr AS; Buckalew AR; Lougee RR; Richard AM; Laws SC; Stoker TE
    Environ Int; 2019 May; 126():377-386. PubMed ID: 30826616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a screening approach to detect thyroid disrupting chemicals that inhibit the human sodium iodide symporter (NIS).
    Hallinger DR; Murr AS; Buckalew AR; Simmons SO; Stoker TE; Laws SC
    Toxicol In Vitro; 2017 Apr; 40():66-78. PubMed ID: 27979590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Screening and Quantitative Chemical Ranking for Sodium-Iodide Symporter Inhibitors in ToxCast Phase I Chemical Library.
    Wang J; Hallinger DR; Murr AS; Buckalew AR; Simmons SO; Laws SC; Stoker TE
    Environ Sci Technol; 2018 May; 52(9):5417-5426. PubMed ID: 29611697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a non-radioactive screening assay to detect chemicals disrupting the human sodium iodide symporter activity.
    Dong H; Atlas E; Wade MG
    Toxicol In Vitro; 2019 Jun; 57():39-47. PubMed ID: 30738889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluorooctane sulfonic acid, a persistent organic pollutant, inhibits iodide accumulation by thyroid follicular cells in vitro.
    Conti A; Strazzeri C; Rhoden KJ
    Mol Cell Endocrinol; 2020 Sep; 515():110922. PubMed ID: 32621861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening the ToxCast Phase 1 Chemical Library for Inhibition of Deiodinase Type 1 Activity.
    Hornung MW; Korte JJ; Olker JH; Denny JS; Knutsen C; Hartig PC; Cardon MC; Degitz SJ
    Toxicol Sci; 2018 Apr; 162(2):570-581. PubMed ID: 29228274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening the ToxCast Phase 1, Phase 2, and e1k Chemical Libraries for Inhibitors of Iodothyronine Deiodinases.
    Olker JH; Korte JJ; Denny JS; Hartig PC; Cardon MC; Knutsen CN; Kent PM; Christensen JP; Degitz SJ; Hornung MW
    Toxicol Sci; 2019 Apr; 168(2):430-442. PubMed ID: 30561685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiered High-Throughput Screening Approach to Identify Thyroperoxidase Inhibitors Within the ToxCast Phase I and II Chemical Libraries.
    Paul Friedman K; Watt ED; Hornung MW; Hedge JM; Judson RS; Crofton KM; Houck KA; Simmons SO
    Toxicol Sci; 2016 May; 151(1):160-80. PubMed ID: 26884060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of potential inhibitors of thyroid iodide uptake by using CHO cells stably expressing the human sodium/iodide symporter (hNIS) protein.
    Agretti P; Dimida A; De Marco G; Ferrarini E; Rodrìguez Gonzàlez JC; Santini F; Vitti P; Pinchera A; Tonacchera M
    J Endocrinol Invest; 2011 Mar; 34(3):170-4. PubMed ID: 20479570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revision of the affinity constant for perchlorate binding to the sodium-iodide symporter based on in vitro and human in vivo data.
    Schlosser PM
    J Appl Toxicol; 2016 Dec; 36(12):1531-1535. PubMed ID: 27177048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro screening for chemical inhibition of the iodide recycling enzyme, iodotyrosine deiodinase.
    Olker JH; Korte JJ; Denny JS; Haselman JT; Hartig PC; Cardon MC; Hornung MW; Degitz SJ
    Toxicol In Vitro; 2021 Mar; 71():105073. PubMed ID: 33352258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Romijn JA; van der Heide D
    Exp Clin Endocrinol Diabetes; 2001; 109(1):52-5. PubMed ID: 11573141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer.
    Oh JM; Baek SH; Gangadaran P; Hong CM; Rajendran RL; Lee HW; Zhu L; Gopal A; Kalimuthu S; Jeong SY; Lee SW; Lee J; Ahn BC
    Thyroid; 2020 Apr; 30(4):501-518. PubMed ID: 31928162
    [No Abstract]   [Full Text] [Related]  

  • 17. MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner.
    Vadysirisack DD; Venkateswaran A; Zhang Z; Jhiang SM
    Endocr Relat Cancer; 2007 Jun; 14(2):421-32. PubMed ID: 17639055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface targeting accounts for the difference in iodide uptake activity between human Na+/I- symporter and rat Na+/I- symporter.
    Zhang Z; Liu YY; Jhiang SM
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6131-40. PubMed ID: 16105966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perchlorate, nitrate, and thiocyanate: Environmental relevant NIS-inhibitors pollutants and their impact on thyroid function and human health.
    Serrano-Nascimento C; Nunes MT
    Front Endocrinol (Lausanne); 2022; 13():995503. PubMed ID: 36339434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Evaluation of the Effects of Legacy and New Generation Perfluoralkyl Substances (PFAS) on Thyroid Cells
    De Toni L; Di Nisio A; Rocca MS; Pedrucci F; Garolla A; Dall'Acqua S; Guidolin D; Ferlin A; Foresta C
    Front Endocrinol (Lausanne); 2022; 13():915096. PubMed ID: 35813651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.